Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Unified.to, the real-time unified API and Model Context Protocol (MCP) platform for B2B SaaS and AI-native teams, today announced a 550% increase in API usage over the past six months, driven by the ...

Regular exposure to GK and current affairs enhances overall awareness, sharpens understanding and supports long-term ...

In 2025, Mantle entered a new phase of its evolution. What began as a high-performance Layer-2 rapidly transformed into a full-stack on-chain financial ecosystem, uniting infrastructure, liquidity, ...

Male infertility is a major issue worldwide and its causes remain unclear. Researchers at the RIKEN Center for Biosystems ...

KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...

Promoting innovation through capital-market innovation and regulatory modernisation, like China did, is the way to go ...

Male infertility is a major issue worldwide and its causes remain unclear. Now, an international team of researchers led by Hiroki Shibuya at the RIKEN Center for Biosystems Dynamics Research (BDR) in ...

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.